Advancements in oncolytic virus therapy: a new horizon for ovarian cancer
Ovarian cancer remains the most lethal gynecological malignancy, and the limited durability of standard treatments has motivated the development of new therapeutic strategies. Oncolytic viruses selectively replicate within and lyse tumor cells, releasing tumor antigens and inflammatory signals that can convert an immun...